98 related articles for article (PubMed ID: 27077771)
1. Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP.
Zhong J; Chen S; Xu L; Lai J; Liao Z; Zhang T; Yu Z; Lu Y; Yang L; Wu X; Li B; Li Y
Hematology; 2016 Oct; 21(9):552-7. PubMed ID: 27077771
[TBL] [Abstract][Full Text] [Related]
2. Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis.
Birtas Atesoglu E; Tarkun P; Demirsoy ET; Geduk A; Mehtap O; Batman A; Kaya F; Cekmen MB; Gulbas Z; Hacıhanefioglu A
Clin Appl Thromb Hemost; 2016 Apr; 22(3):248-51. PubMed ID: 25510412
[TBL] [Abstract][Full Text] [Related]
3. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
[TBL] [Abstract][Full Text] [Related]
4. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP).
Zhu F; Qiao J; Cao J; Sun HY; Wu QY; Sun ZT; Zhao K; Sang W; Qi KM; Zeng LY; Li ZY; Xu KL
Thromb Res; 2015 Oct; 136(4):797-802. PubMed ID: 26272303
[TBL] [Abstract][Full Text] [Related]
5. Percentages of PD-1
Wang Y; Pang N; Wang X; Liu Y; Wang X; Wang L; Sun M; Yasen H; Zhao F; Fan W; Guo X; Ding J
Hum Vaccin Immunother; 2018 Apr; 14(4):832-838. PubMed ID: 29333980
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
7. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
[TBL] [Abstract][Full Text] [Related]
8. The feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura.
Zhang X; Chen S; Yang L; Li B; Zhu K; Li Y
Hematology; 2009 Aug; 14(4):237-44. PubMed ID: 19635188
[TBL] [Abstract][Full Text] [Related]
9. Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.
Xie J; Cui D; Liu Y; Jin J; Tong H; Wang L; Ruan G; Lu Y; Yuan H
Int J Biol Sci; 2015; 11(2):220-9. PubMed ID: 25561904
[TBL] [Abstract][Full Text] [Related]
10. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
[TBL] [Abstract][Full Text] [Related]
11. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction
Han P; Yu T; Hou Y; Zhao Y; Liu Y; Sun Y; Wang H; Xu P; Li G; Sun T; Hu X; Liu X; Li L; Peng J; Zhou H; Hou M
Front Immunol; 2021; 12():630693. PubMed ID: 33679776
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type.
Jo JC; Kim M; Choi Y; Kim HJ; Kim JE; Chae SW; Kim H; Cha HJ
Ann Hematol; 2017 Jan; 96(1):25-31. PubMed ID: 27696202
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
[TBL] [Abstract][Full Text] [Related]
15. Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia.
Grzywnowicz M; Karczmarczyk A; Skorka K; Zajac M; Zaleska J; Chocholska S; Tomczak W; Giannopoulos K
Acta Haematol; 2015; 134(4):255-62. PubMed ID: 26159545
[TBL] [Abstract][Full Text] [Related]
16. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
[TBL] [Abstract][Full Text] [Related]
17. Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.
Friedman CF; Postow MA
Curr Oncol Rep; 2016 Apr; 18(4):21. PubMed ID: 26922327
[TBL] [Abstract][Full Text] [Related]
18. Lack of impact of cytotoxic T-lymphocyte antigen 4 gene exon 1 polymorphism on susceptibility to or clinical course of egyptian childhood immune thrombocytopenic purpura.
Radwan ER; Goda RL
Clin Appl Thromb Hemost; 2015 May; 21(4):378-82. PubMed ID: 24023266
[TBL] [Abstract][Full Text] [Related]
19. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
[TBL] [Abstract][Full Text] [Related]
20. [The role of DNA methylation in the pathogenesis of adult idiopathic thrombocytopenic purpura].
Tao J; Yang M; Chen Z; Zhang WH; Zhang XL; Yang RC
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):208-12. PubMed ID: 20450651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
